Literature DB >> 26580675

Antitumor activity and systemic effects of PVM/MA-shelled selol nanocapsules in lung adenocarcinoma-bearing mice.

Ludmilla Regina de Souza1, Luis Alexandre Muehlmann, Lívia Carneiro Matos, Rosana Simón-Vázquez, Zulmira Guerreiro Marques Lacava, Alfredo Maurício Batista De-Paula, Ewa Mosiniewicz-Szablewska, Piotr Suchocki, Paulo César Morais, África González-Fernández, Sônia Nair Báo, Ricardo Bentes Azevedo.   

Abstract

Selol is a semi-synthetic compound containing selenite that is effective against cancerous cells and safer for clinical applications in comparison with other inorganic forms of selenite. Recently, we have developed a formulation of poly(methyl vinyl ether-co-maleic anhydride)-shelled selol nanocapsules (SPN), which reduced the proliferative activity of lung adenocarcinoma cells and presented little deleterious effects on normal cells in in vitro studies. In this study, we report on the antitumor activity and systemic effects induced by this formulation in chemically induced lung adenocarcinoma-bearing mice. The in vivo antitumor activity of the SPN was verified by macroscopic quantification, immunohistochemistry and morphological analyses. Toxicity analyses were performed by evaluations of the kidney, liver, and spleen; analyses of hemogram and plasma levels of alanine aminotransferase, aspartate transaminase, urea, and creatinine; and DNA fragmentation and cell cycle activity of the bone marrow cells. Furthermore, we investigated the potential of the SPN formulation to cause hemolysis, activate the complement system, provoke an inflammatory response and change the conformation of the plasma proteins. Our results showed that the SPN reduced the area of the surface tumor nodules but not the total number of tumor nodules. The biochemical and hematological findings were suggestive of the low systemic toxicity of the SPN formulation. The surface properties of the selol nanocapsules point to characteristics that are consistent with the treatment of the tumors in vivo: low hemolytic activity, weak inflammatory reaction with no activation of the complement system, and mild or absent conformational changes of the plasma proteins. In conclusion, this report suggests that the SPN formulation investigated herein exhibits anti-tumoral effects against lung adenocarcinoma in vivo and is associated with low systemic toxicity and high biocompatibility.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26580675     DOI: 10.1088/0957-4484/26/50/505101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  2 in total

1.  Protective Effects of Selol Against Sodium Nitroprusside-Induced Cell Death and Oxidative Stress in PC12 Cells.

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Henryk Jęśko; Agata Adamczyk
Journal:  Neurochem Res       Date:  2016-09-02       Impact factor: 3.996

2.  Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer.

Authors:  Wenqian Zheng; Jinhui Hu; Yiming Lv; Bingjun Bai; Lina Shan; Kangke Chen; Sheng Dai; Hongbo Zhu
Journal:  Med Oncol       Date:  2021-02-08       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.